“Testosterone Kit” in Patent Application Approval Process (USPTO 20160120712)
By a
This patent application has not been assigned to a company or institution.
The following quote was obtained by the news editors from the background information supplied by the inventors: "With the changing reimbursements, types of health care insurance, and new regulations with regards to treatment, a medical practitioner and his/her team when treating a patient is under immense time pressures to perform quickly, efficiently and with safety for the patient. If a patient requires a singular or even multiple injections, the medical practitioner must rely on his/her team to first locate the necessary and correct injectable medications, insure they are the correct strength and percentage, insure dating is current, insure the top has not been contaminated, insure the liquid is not crystallized, or containing growth, insure there is sufficient medication in the vial, and insure that the injection has been stored at the proper temperature and humidity as well as all other possible, related materials and safety precautions needed to treat the patient. The medical practitioner can lose valuable time trying to not only locate the necessary drugs and materials to treat the patient but as well to insure the compliance, the safety of the patient by preventing contamination. In some instances, not all the drugs and materials may be readily available, in the current exam room, resulting in delayed treatment and possible and potential medical errors. In addition, the medical practitioner or his/her team may make a mistake by incorrectly choosing the drug, by incorrectly identifying the product, not checking the expiration date, not returning it to the proper environment for storage, or not having enough product and thus requiring an additional sterile vial to be opened to inject directly into the veins of a patient.
"There is a need in the art for a convenience kit that solves the above mentioned problems in the medical practitioner office."
In addition to the background information obtained for this patent application, VerticalNews journalists also obtained the inventor's summary information for this patent application: "Provided is a kit comprising a holder and following components placed inside a holder: a) a container of testosterone ester; b) a pad for disinfecting or cleaning an injection site; c) a pair of gloves; and d) optionally a CSR wrap. The testosterone ester can be testosterone cypionate or testosterone enanthate. The strength of the testosterone ester can be about 25 mg/ml to about 250 mg/ml, such as 100 mg/ml or 200 mg/ml. The amount of the testosterone ester can be about 1 to about 10 ml, such as about 1 ml, about 5 ml or about 10 ml. In one embodiment, testosterone cypionate at a strength of 200 mg/ml and amount of 1 ml is used. The pad can be an alcohol pad, such as an isopropyl pad. The isopropyl pad can have a strength of about 70%. The kit can further include an instruction sheet.
"Provided is a kit comprising a box with a lit and following components placed inside a holder: a) a container of testosterone cypionate with a strength and an amount of 200 mg/ml (1 ml) USP (United States Pharmacopeia) in a formulation that is suitable for injection to an animal; b) an alcohol pad for disinfecting or cleaning an injection site; c) a pair of gloves; d) a CSR wrap; and e) an instruction sheet.
BRIEF DESCRIPTION OF THE FIGURES
"FIG. 1 illustrates a box for placing the various components of the kit.
"FIG. 2 illustrates an instruction sheet.
"FIG. 3 illustrates a box for placing a drug vial.
"FIG. 4 illustrates a drug vial.
"FIG. 5 illustrates a drug ampule.
"FIG. 6 illustrates a CSR wrap.
"FIG. 7 illustrates a glove.
"FIG. 8 illustrates a pad."
URL and more information on this patent application, see: Nickell, Robert P. Testosterone Kit. Filed
Keywords for this news article include: Patents.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2016, NewsRx LLC



Advisor News
- Report: Many Americans paying up to 45% of annual income on auto loans
- Latest state budget raises taxes on Californians, ignores voter priorities
- What advisors and clients must know about Roth conversions
- Worker retirement confidence dips to lowest level in a decade
- What’s behind private equity investment in insurance brokerages
More Advisor NewsAnnuity News
- Globe Life Inc. (NYSE: GL) Making Surprising Moves in Tuesday Session
- Why annuities are gaining traction with younger investors
- Best’s Special Report: U.S. Life/Annuity Industry Sees Bottom-Line Growth Despite 18% Decline in Total Income in First-Quarter 2026
- Globe Life Inc. (NYSE: GL) Records 52-Week High Thursday Morning
- Fortitude Re Completes $500 Million FABN Issuance
More Annuity NewsHealth/Employee Benefits News
- REP. GOLDMAN INTRODUCES THE BETTER CARE, BETTER COST ACT TO STRENGTHEN MEDICAID
- New task force targets rising health insurance costs
- Thousands in Wyoming are paying sky-high health insurance costs. A new task force is digging into why
- Bohannan tours Park Place Long-Term Care nursing home in Mt. Pleasant
- Wyoming lawmakers mull solutions to rising healthcare costs
More Health/Employee Benefits NewsLife Insurance News
- Avoid the ‘summertime slump:’ Strategies to remain productive
- Globe Life Inc. (NYSE: GL) Making Surprising Moves in Tuesday Session
- Symetra Partners with PlanSource to Streamline Workforce Benefits Administration
- Royal Neighbors of America achieves record growth
- Only 1 in 4 Americans Think Now Is A Good Time To Invest, Allianz Life Study Finds
More Life Insurance News